Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Discover reliable places to access index level fundamentals and tips for evaluating the credibility and timeliness of the data you use.
17,495 articlesEli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
A big insider move at a major insurer has analysts and traders watching closely. Learn what assured guaranty’s inside...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
A recent SEC filing shows Brightlight Capital trimmed its Hilton stake by 79,500 shares, reducing the position's valu...
Microsoft delivered a powerful May with a 10.4% jump, but June brought a dampening mood. This article breaks down wha...
When a top executive sells a large block, investors want to know what it really signals. This analysis breaks down th...
A Gold.com board director sold a sizable stake as bullion endured its worst week in decades. This article explains wh...
As AI reshapes tech investing, the question lingers: should chip stocks dip? This piece blends Jensen Huang’s long‑te...
When a CEO sells thousands of shares, investors want to know what it signals. This guide explains how to read insider...
On a day when the markets attempted a comeback, FuboTV stunned traders with a sharp drop. This article breaks down wh...